nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—GSK3B—eye—ocular cancer	0.0104	0.188	CbGeAlD
Lithium—IMPA1—lymphoid tissue—ocular cancer	0.00997	0.18	CbGeAlD
Lithium—GSK3B—epithelium—ocular cancer	0.00953	0.172	CbGeAlD
Lithium—GSK3A—eye—ocular cancer	0.00906	0.164	CbGeAlD
Lithium—GSK3A—retina—ocular cancer	0.00898	0.162	CbGeAlD
Lithium—GSK3B—lymphoid tissue—ocular cancer	0.00734	0.133	CbGeAlD
Lithium—GSK3B—DAP12 signaling—CDKN1A—ocular cancer	0.000796	0.000843	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—CDKN1B—ocular cancer	0.000794	0.00084	CbGpPWpGaD
Lithium—GSK3B—Cell Cycle—TP53—ocular cancer	0.000793	0.000839	CbGpPWpGaD
Lithium—GSK3B—Wnt Signaling Pathway and Pluripotency—TP53—ocular cancer	0.000793	0.000839	CbGpPWpGaD
Lithium—GSK3A—Signaling by SCF-KIT—HRAS—ocular cancer	0.000792	0.000838	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000791	0.000837	CbGpPWpGaD
Lithium—GSK3B—B Cell Receptor Signaling Pathway—HRAS—ocular cancer	0.000789	0.000835	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000789	0.000835	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—MDM2—ocular cancer	0.000787	0.000833	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—E2F5—ocular cancer	0.000787	0.000833	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—CDKN1A—ocular cancer	0.000785	0.000831	CbGpPWpGaD
Lithium—GSK3A—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.000784	0.00083	CbGpPWpGaD
Lithium—GSK3B—MicroRNAs in cardiomyocyte hypertrophy—AKT1—ocular cancer	0.000782	0.000828	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—TP53—ocular cancer	0.000775	0.00082	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—E2F4—ocular cancer	0.000771	0.000816	CbGpPWpGaD
Lithium—GSK3B—Constitutive PI3K/AKT Signaling in Cancer—AKT1—ocular cancer	0.000767	0.000812	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling of activated FGFR—HRAS—ocular cancer	0.000758	0.000802	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—RB1—ocular cancer	0.000757	0.000802	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RBL1—ocular cancer	0.000756	0.0008	CbGpPWpGaD
Lithium—GSK3B—DNA Damage Response (only ATM dependent)—TP53—ocular cancer	0.000752	0.000796	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—CDKN1B—ocular cancer	0.000751	0.000795	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—CDKN1A—ocular cancer	0.000749	0.000793	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—CDKN1A—ocular cancer	0.000749	0.000793	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—CDKN1A—ocular cancer	0.000749	0.000793	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—CDKN1B—ocular cancer	0.000748	0.000792	CbGpPWpGaD
Lithium—GSK3B—Androgen receptor signaling pathway—AKT1—ocular cancer	0.000747	0.00079	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB4—HRAS—ocular cancer	0.000746	0.000789	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—CDKN1A—ocular cancer	0.000742	0.000786	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—HRAS—ocular cancer	0.000741	0.000784	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—CDKN1A—ocular cancer	0.000736	0.000779	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—CDKN1A—ocular cancer	0.000733	0.000775	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—CCND1—ocular cancer	0.000732	0.000774	CbGpPWpGaD
Lithium—GSK3B—Corticotropin-releasing hormone—AKT1—ocular cancer	0.000727	0.00077	CbGpPWpGaD
Lithium—GSK3B—DNA Damage Response (only ATM dependent)—HRAS—ocular cancer	0.000719	0.000761	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—CDKN1B—ocular cancer	0.000719	0.000761	CbGpPWpGaD
Lithium—GSK3A—Insulin Signaling—HRAS—ocular cancer	0.000716	0.000758	CbGpPWpGaD
Lithium—GSK3A—Downstream signal transduction—HRAS—ocular cancer	0.000712	0.000754	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR—HRAS—ocular cancer	0.000709	0.00075	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB2—HRAS—ocular cancer	0.000705	0.000746	CbGpPWpGaD
Lithium—GSK3A—DAP12 signaling—HRAS—ocular cancer	0.000702	0.000743	CbGpPWpGaD
Lithium—GSK3A—Signaling by SCF-KIT—AKT1—ocular cancer	0.000699	0.00074	CbGpPWpGaD
Lithium—GSK3B—B Cell Receptor Signaling Pathway—AKT1—ocular cancer	0.000697	0.000738	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—CDKN1A—ocular cancer	0.000693	0.000734	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling events of B Cell Receptor (BCR)—HRAS—ocular cancer	0.000692	0.000732	CbGpPWpGaD
Lithium—GSK3A—Disease—MAML2—ocular cancer	0.000691	0.000732	CbGpPWpGaD
Lithium—GSK3B—PI-3K cascade—AKT1—ocular cancer	0.000691	0.000732	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—CDKN1A—ocular cancer	0.000691	0.000731	CbGpPWpGaD
Lithium—GSK3B—PI3K/AKT activation—AKT1—ocular cancer	0.000675	0.000714	CbGpPWpGaD
Lithium—GSK3B—GAB1 signalosome—AKT1—ocular cancer	0.000669	0.000709	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling of activated FGFR—AKT1—ocular cancer	0.000669	0.000708	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—CDKN1A—ocular cancer	0.000663	0.000702	CbGpPWpGaD
Lithium—GSK3A—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.000662	0.000701	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—HRAS—ocular cancer	0.00066	0.000699	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—HRAS—ocular cancer	0.00066	0.000699	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—HRAS—ocular cancer	0.00066	0.000699	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB4—AKT1—ocular cancer	0.000658	0.000697	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SAG—ocular cancer	0.000657	0.000696	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—E2F3—ocular cancer	0.000656	0.000694	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—HRAS—ocular cancer	0.000654	0.000693	CbGpPWpGaD
Lithium—GSK3B—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—ocular cancer	0.000654	0.000692	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000649	0.000688	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR in Cancer—HRAS—ocular cancer	0.000648	0.000686	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—MDM2—ocular cancer	0.000646	0.000683	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—HRAS—ocular cancer	0.000646	0.000683	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—EP300—ocular cancer	0.000644	0.000682	CbGpPWpGaD
Lithium—GSK3B—Disease—TFDP1—ocular cancer	0.000643	0.000681	CbGpPWpGaD
Lithium—GRIA3—Neuronal System—HRAS—ocular cancer	0.00064	0.000678	CbGpPWpGaD
Lithium—GSK3B—DNA Damage Response (only ATM dependent)—AKT1—ocular cancer	0.000635	0.000672	CbGpPWpGaD
Lithium—GSK3A—Insulin Signaling—AKT1—ocular cancer	0.000632	0.000669	CbGpPWpGaD
Lithium—GSK3A—Downstream signal transduction—AKT1—ocular cancer	0.000629	0.000666	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR—AKT1—ocular cancer	0.000626	0.000662	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB2—AKT1—ocular cancer	0.000623	0.000659	CbGpPWpGaD
Lithium—GSK3A—DAP12 signaling—AKT1—ocular cancer	0.00062	0.000656	CbGpPWpGaD
Lithium—GSK3A—B Cell Activation—HRAS—ocular cancer	0.000611	0.000647	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling events of B Cell Receptor (BCR)—AKT1—ocular cancer	0.000611	0.000646	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TFDP1—ocular cancer	0.000609	0.000645	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—MDM2—ocular cancer	0.000606	0.000641	CbGpPWpGaD
Lithium—GSK3B—TCF dependent signaling in response to WNT—EP300—ocular cancer	0.000603	0.000639	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—CDKN1B—ocular cancer	0.00059	0.000624	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—HRAS—ocular cancer	0.000585	0.000619	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	0.000585	0.000619	CbGpPWpGaD
Lithium—GSK3B—RNF mutants show enhanced WNT signaling and proliferation—EP300—ocular cancer	0.000584	0.000618	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—AKT1—ocular cancer	0.000583	0.000617	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—AKT1—ocular cancer	0.000583	0.000617	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	0.000583	0.000617	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—E2F5—ocular cancer	0.000582	0.000616	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—AKT1—ocular cancer	0.000578	0.000611	CbGpPWpGaD
Lithium—GSK3B—BDNF signaling pathway—HRAS—ocular cancer	0.000575	0.000609	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR in Cancer—AKT1—ocular cancer	0.000573	0.000606	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—AKT1—ocular cancer	0.00057	0.000603	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—E2F4—ocular cancer	0.00057	0.000603	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—HRAS—ocular cancer	0.00056	0.000593	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RBL1—ocular cancer	0.000559	0.000591	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—CDKN1B—ocular cancer	0.000553	0.000585	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—HRAS—ocular cancer	0.000551	0.000583	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000548	0.000581	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—CDKN1A—ocular cancer	0.000544	0.000576	CbGpPWpGaD
Lithium—GSK3B—Signaling by WNT in cancer—EP300—ocular cancer	0.000542	0.000574	CbGpPWpGaD
Lithium—GSK3A—B Cell Activation—AKT1—ocular cancer	0.000539	0.000571	CbGpPWpGaD
Lithium—GSK3B—Insulin Signaling—HRAS—ocular cancer	0.000529	0.00056	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—CDK4—ocular cancer	0.000528	0.000558	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—HRAS—ocular cancer	0.000526	0.000557	CbGpPWpGaD
Lithium—GSK3B—TCF dependent signaling in response to WNT—MYC—ocular cancer	0.000526	0.000557	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—HRAS—ocular cancer	0.000524	0.000554	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—HRAS—ocular cancer	0.000521	0.000552	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—HRAS—ocular cancer	0.000519	0.000549	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—EP300—ocular cancer	0.000518	0.000548	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—AKT1—ocular cancer	0.000517	0.000547	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	0.000516	0.000546	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—HRAS—ocular cancer	0.000511	0.000541	CbGpPWpGaD
Lithium—GSK3B—Disease—MAML2—ocular cancer	0.000511	0.000541	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—CDKN1A—ocular cancer	0.00051	0.00054	CbGpPWpGaD
Lithium—GSK3B—RNF mutants show enhanced WNT signaling and proliferation—MYC—ocular cancer	0.000509	0.000539	CbGpPWpGaD
Lithium—GSK3B—BDNF signaling pathway—AKT1—ocular cancer	0.000508	0.000538	CbGpPWpGaD
Lithium—GSK3A—Disease—HDAC1—ocular cancer	0.000506	0.000535	CbGpPWpGaD
Lithium—IMPA2—Metabolism—EP300—ocular cancer	0.000503	0.000532	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—AKT1—ocular cancer	0.000494	0.000523	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—HRAS—ocular cancer	0.000488	0.000516	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—HRAS—ocular cancer	0.000488	0.000516	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—HRAS—ocular cancer	0.000488	0.000516	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—AKT1—ocular cancer	0.000487	0.000515	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—E2F3—ocular cancer	0.000484	0.000513	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MAML2—ocular cancer	0.000484	0.000512	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—HRAS—ocular cancer	0.000483	0.000512	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—HRAS—ocular cancer	0.000479	0.000507	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—HRAS—ocular cancer	0.000477	0.000505	CbGpPWpGaD
Lithium—GSK3B—Signaling by WNT in cancer—MYC—ocular cancer	0.000473	0.0005	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—MDM2—ocular cancer	0.000467	0.000495	CbGpPWpGaD
Lithium—GSK3B—Insulin Signaling—AKT1—ocular cancer	0.000467	0.000494	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—AKT1—ocular cancer	0.000465	0.000492	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—AKT1—ocular cancer	0.000462	0.000489	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—HRAS—ocular cancer	0.000461	0.000488	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—TP53—ocular cancer	0.000461	0.000488	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—AKT1—ocular cancer	0.00046	0.000487	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—AKT1—ocular cancer	0.000458	0.000485	CbGpPWpGaD
Lithium—GSK3A—Disease—CDKN2B—ocular cancer	0.000453	0.00048	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—HRAS—ocular cancer	0.000451	0.000478	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—AKT1—ocular cancer	0.000451	0.000478	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TFDP1—ocular cancer	0.00045	0.000477	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—HRAS—ocular cancer	0.00045	0.000476	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—MDM2—ocular cancer	0.000449	0.000475	CbGpPWpGaD
Lithium—IMPA1—Metabolism—EP300—ocular cancer	0.000448	0.000475	CbGpPWpGaD
Lithium—GSK3B—Signaling by Wnt—EP300—ocular cancer	0.000447	0.000473	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	0.000432	0.000457	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	0.000431	0.000456	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—AKT1—ocular cancer	0.000431	0.000456	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—AKT1—ocular cancer	0.000431	0.000456	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—AKT1—ocular cancer	0.000427	0.000452	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CDKN1B—ocular cancer	0.000427	0.000452	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—AKT1—ocular cancer	0.000423	0.000448	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—GNA11—ocular cancer	0.000422	0.000447	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—AKT1—ocular cancer	0.000421	0.000446	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CDKN1B—ocular cancer	0.00041	0.000434	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—AKT1—ocular cancer	0.000407	0.000431	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—AKT1—ocular cancer	0.000399	0.000422	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—AKT1—ocular cancer	0.000397	0.00042	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CDKN1A—ocular cancer	0.000394	0.000417	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—GNAQ—ocular cancer	0.000393	0.000416	CbGpPWpGaD
Lithium—GSK3B—Signaling by Wnt—MYC—ocular cancer	0.00039	0.000412	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	0.000381	0.000404	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CDKN1A—ocular cancer	0.000378	0.0004	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—EP300—ocular cancer	0.000375	0.000397	CbGpPWpGaD
Lithium—GSK3B—Disease—HDAC1—ocular cancer	0.000374	0.000395	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—TP53—ocular cancer	0.00037	0.000392	CbGpPWpGaD
Lithium—GSK3B—TCF dependent signaling in response to WNT—AKT1—ocular cancer	0.000365	0.000386	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MAML2—ocular cancer	0.000358	0.000379	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HDAC1—ocular cancer	0.000354	0.000375	CbGpPWpGaD
Lithium—GSK3B—RNF mutants show enhanced WNT signaling and proliferation—AKT1—ocular cancer	0.000353	0.000374	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—MDM2—ocular cancer	0.000345	0.000366	CbGpPWpGaD
Lithium—GSK3B—Disease—CDKN2B—ocular cancer	0.000335	0.000354	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—HRAS—ocular cancer	0.000332	0.000352	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—MDM2—ocular cancer	0.000332	0.000351	CbGpPWpGaD
Lithium—GSK3B—Signaling by WNT in cancer—AKT1—ocular cancer	0.000328	0.000347	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CDKN2B—ocular cancer	0.000317	0.000336	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CDKN1B—ocular cancer	0.000315	0.000334	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—EP300—ocular cancer	0.000314	0.000332	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GNA11—ocular cancer	0.000312	0.00033	CbGpPWpGaD
Lithium—IMPA2—Metabolism—AKT1—ocular cancer	0.000304	0.000322	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CDKN1B—ocular cancer	0.000303	0.000321	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—HRAS—ocular cancer	0.000301	0.000318	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—AKT1—ocular cancer	0.000293	0.000311	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—E2F1—ocular cancer	0.000291	0.000308	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CDKN1A—ocular cancer	0.000291	0.000308	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GNAQ—ocular cancer	0.00029	0.000307	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CDKN1A—ocular cancer	0.000279	0.000296	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—EP300—ocular cancer	0.000277	0.000293	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TGFB1—ocular cancer	0.000273	0.000289	CbGpPWpGaD
Lithium—GSK3A—Immune System—MDM2—ocular cancer	0.000272	0.000288	CbGpPWpGaD
Lithium—IMPA1—Metabolism—AKT1—ocular cancer	0.000271	0.000287	CbGpPWpGaD
Lithium—GSK3B—Signaling by Wnt—AKT1—ocular cancer	0.00027	0.000286	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HDAC1—ocular cancer	0.000262	0.000277	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—HRAS—ocular cancer	0.000256	0.000272	CbGpPWpGaD
Lithium—GSK3A—Disease—MDM2—ocular cancer	0.000251	0.000266	CbGpPWpGaD
Lithium—GSK3A—Immune System—CDKN1B—ocular cancer	0.000249	0.000263	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—HRAS—ocular cancer	0.000246	0.000261	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CDKN2B—ocular cancer	0.000234	0.000248	CbGpPWpGaD
Lithium—GSK3A—Disease—CDKN1B—ocular cancer	0.00023	0.000243	CbGpPWpGaD
Lithium—GSK3A—Immune System—CDKN1A—ocular cancer	0.000229	0.000243	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—AKT1—ocular cancer	0.000226	0.00024	CbGpPWpGaD
Lithium—GSK3A—Immune System—EP300—ocular cancer	0.000218	0.000231	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—AKT1—ocular cancer	0.000217	0.00023	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—E2F1—ocular cancer	0.000215	0.000228	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—HRAS—ocular cancer	0.000215	0.000227	CbGpPWpGaD
Lithium—GSK3A—Disease—CDKN1A—ocular cancer	0.000212	0.000224	CbGpPWpGaD
Lithium—GSK3A—Disease—EP300—ocular cancer	0.000202	0.000213	CbGpPWpGaD
Lithium—GSK3B—Immune System—MDM2—ocular cancer	0.000201	0.000213	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—HRAS—ocular cancer	0.00019	0.000201	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—AKT1—ocular cancer	0.000189	0.000201	CbGpPWpGaD
Lithium—GSK3B—Disease—MDM2—ocular cancer	0.000186	0.000197	CbGpPWpGaD
Lithium—GSK3B—Immune System—CDKN1B—ocular cancer	0.000184	0.000194	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—HRAS—ocular cancer	0.000182	0.000193	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MDM2—ocular cancer	0.000176	0.000186	CbGpPWpGaD
Lithium—GSK3A—Disease—MYC—ocular cancer	0.000176	0.000186	CbGpPWpGaD
Lithium—GSK3A—Disease—TGFB1—ocular cancer	0.000175	0.000185	CbGpPWpGaD
Lithium—GSK3B—Disease—CDKN1B—ocular cancer	0.00017	0.00018	CbGpPWpGaD
Lithium—GSK3B—Immune System—CDKN1A—ocular cancer	0.00017	0.000179	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—AKT1—ocular cancer	0.000167	0.000177	CbGpPWpGaD
Lithium—GSK3B—Immune System—EP300—ocular cancer	0.000161	0.000171	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CDKN1B—ocular cancer	0.000161	0.00017	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—AKT1—ocular cancer	0.000161	0.00017	CbGpPWpGaD
Lithium—GSK3B—Disease—CDKN1A—ocular cancer	0.000157	0.000166	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCND1—ocular cancer	0.000153	0.000162	CbGpPWpGaD
Lithium—GSK3A—Immune System—HRAS—ocular cancer	0.000149	0.000158	CbGpPWpGaD
Lithium—GSK3B—Disease—EP300—ocular cancer	0.000149	0.000158	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CDKN1A—ocular cancer	0.000148	0.000157	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—EP300—ocular cancer	0.000141	0.000149	CbGpPWpGaD
Lithium—GSK3A—Disease—HRAS—ocular cancer	0.000138	0.000146	CbGpPWpGaD
Lithium—GSK3A—Immune System—AKT1—ocular cancer	0.000132	0.00014	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MDM2—ocular cancer	0.00013	0.000138	CbGpPWpGaD
Lithium—GSK3B—Disease—MYC—ocular cancer	0.00013	0.000137	CbGpPWpGaD
Lithium—GSK3B—Disease—TGFB1—ocular cancer	0.000129	0.000137	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MYC—ocular cancer	0.000123	0.00013	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TGFB1—ocular cancer	0.000123	0.00013	CbGpPWpGaD
Lithium—GSK3A—Disease—AKT1—ocular cancer	0.000122	0.000129	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CDKN1B—ocular cancer	0.000119	0.000126	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCND1—ocular cancer	0.000113	0.00012	CbGpPWpGaD
Lithium—GSK3B—Immune System—HRAS—ocular cancer	0.00011	0.000117	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CDKN1A—ocular cancer	0.00011	0.000116	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—EP300—ocular cancer	0.000104	0.00011	CbGpPWpGaD
Lithium—GSK3B—Disease—HRAS—ocular cancer	0.000102	0.000108	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TP53—ocular cancer	0.000101	0.000107	CbGpPWpGaD
Lithium—GSK3B—Immune System—AKT1—ocular cancer	9.75e-05	0.000103	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HRAS—ocular cancer	9.66e-05	0.000102	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MYC—ocular cancer	9.09e-05	9.62e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TGFB1—ocular cancer	9.07e-05	9.6e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—AKT1—ocular cancer	9e-05	9.53e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—AKT1—ocular cancer	8.53e-05	9.03e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TP53—ocular cancer	7.46e-05	7.9e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HRAS—ocular cancer	7.14e-05	7.56e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AKT1—ocular cancer	6.3e-05	6.67e-05	CbGpPWpGaD
